Dronabinol + Alcohol for Driving Performance
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores the combined effects of cannabis and alcohol on driving. It examines how different doses of dronabinol (a form of THC), both alone and with alcohol, impact driving skills and subjective experiences. The trial aims to address gaps in understanding THC's effects on driving, particularly when mixed with alcohol. Participants should be healthy adults who have occasionally used cannabis and can consume alcohol without major side effects. As a Phase 1 trial, the research focuses on understanding how the treatment works in people, offering participants the chance to contribute to groundbreaking research on THC and driving safety.
Will I have to stop taking my current medications?
Participants must stop using any medications other than birth control 14 days before the study, unless the investigator approves them.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
In a previous study, participants who took dronabinol (a form of THC, the main ingredient in cannabis) experienced some difficulty driving shortly after use. Most reported worse driving for a few hours, but it typically returned to normal after about 4-7 hours. This indicates that while dronabinol can affect driving, these effects are temporary and generally resolve within a few hours.
The FDA (Food and Drug Administration) has already approved dronabinol for treating nausea and appetite loss, indicating its safety for these uses. However, this trial tests dronabinol with alcohol, which might produce different effects, making it important to understand their interaction.
Overall, dronabinol appears well-tolerated, but caution is advised, especially when combined with alcohol. Consider personal health and comfort when deciding to join a clinical trial.12345Why are researchers excited about this trial's treatments?
Researchers are excited about these treatments because they combine dronabinol (a synthetic form of THC) with alcohol to explore their combined effects on driving performance. Unlike standard treatments that focus on either alcohol or THC separately, this study investigates how their interaction impacts driving abilities. By examining different doses and combinations, researchers aim to better understand the risks and inform safer usage guidelines, especially as cannabis legalization expands. This research is innovative because it provides new insights into how these substances affect driving when used together, which is crucial for public safety.
What evidence suggests that this trial's treatments could be effective for driving performance?
This trial will evaluate the effects of different doses of dronabinol, a type of THC (tetrahydrocannabinol), on driving performance. Research has shown that dronabinol can affect the ability to drive safely. Studies have found that cannabis high in THC can impair driving, while cannabis high in CBD does not. Dronabinol impacts driving skills in both occasional and frequent users, with effects depending on the dose taken. For instance, after taking 20 mg of THC, driving skills might return to normal within about 5 to 7 hours. This trial will specifically assess smaller doses, like 5 mg or 10 mg, to understand how they might affect driving differently.34567
Who Is on the Research Team?
Melanie Fein, MD
Principal Investigator
Spaulding Clinical Research LLC
Are You a Good Fit for This Trial?
This trial is for healthy adults interested in assessing the impact of oral Δ9-THC, with or without alcohol, on driving performance and perception. Participants must meet undisclosed specific criteria to join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive single oral doses across six treatment conditions: 5 mg THC, 10 mg THC, 5 mg THC with alcohol, 10 mg THC with alcohol, alcohol alone, and placebo, with washout periods between treatments
Assessment
Driving performance and subjective effects are assessed using a driving simulator and Visual Analogue Scales (VAS) at baseline and predetermined intervals post-dose
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Dronabinol (Marinol®)
Trial Overview
The study tests how different doses of oral Δ9-THC affect driving skills and subjective feelings alone and when combined with a controlled amount of alcohol (0.08% BAC).
How Is the Trial Designed?
6
Treatment groups
Experimental Treatment
Active Control
Placebo Group
Subjects in this arm will receive one 10 mg oral dose of THC and an alcohol beverage targeting a blood alcohol concentration (BAC) of 0.08%
Subjects in this arm will receive one 5 mg oral dose of THC and an alcohol beverage targeting a blood alcohol concentration (BAC) of 0.08%
Subjects in this arm will receive one 10 mg oral dose of THC and a placebo beverage
Subjects in this arm will receive one 5 mg oral dose of THC and a placebo beverage
Subjects in this arm will receive one placebo capsule and an alcohol beverage targeting a blood alcohol concentration (BAC) of 0.08% as a positive control
Subjects in this arm will receive one placebo capsule and a placebo beverage
Find a Clinic Near You
Who Is Running the Clinical Trial?
Food and Drug Administration (FDA)
Lead Sponsor
Spaulding Clinical Research LLC
Collaborator
Citations
NCT07176208 | Clinical Study to Evaluate the Effects of ...
The results of this study will address current knowledge gaps on the effects of oral Δ9-THC on driving impairment across a clinically relevant dose range.
tetrahydrocannabinol (Δ 9 -THC)-induced driving and ...
Most driving-related skills are predicted to recover within ∼5-hs (and almost all within ∼7-hs) of inhaling 20 mg Δ 9 -THC.
Cannabis Effects on Driving Performance: Clinical ...
Media coverage of this study conveyed the findings as CBD-dominant cannabis not causing driving impairment while THC-dominant cannabis does, ...
Effect of Cannabidiol and Δ9-Tetrahydrocannabinol on ...
This study did not find statistically significant differences in driving performance during experimental on-road driving tests between CBD-dominant cannabis ...
Medicinal Δ9‐tetrahydrocannabinol (dronabinol) impairs ...
Dronabinol (medicinal tetrahydrocannabinol) impairs driving performance in occasional and heavy users in a dose-dependent way, but to a lesser ...
Driving Performance and Cannabis Users' Perception of ...
Worse driving performance is evident for several hours postsmoking in many users but appears to resolve by 4 hours 30 minutes in most ...
Driving Performance and Cannabis Users' Perception of ...
Perception of driving impairment decreased at 1 hour 30 minutes, despite no objective improvement in driving; on average, performance was ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.